Publications by authors named "Andrew Bathgate"

Claim this Profile
C
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
Hamish Innes, Victoria Hamill, Scott A McDonald, Peter C Hayes, Philip Johnson, Andrew Bathgate

Am J Gastroenterol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study.
Hamish Innes, Scott A McDonald, Victoria Hamill, Alan Yeung, John F Dillon, Andrew Bathgate

Liver Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making.
Hamish Innes, Philip Johnson, Scott A McDonald, Victoria Hamill, Alan Yeung, Andrew Bathgate

Gastro Hep Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection.
Hamish Innes, Peter Jepsen, Scott McDonald, John Dillon, Victoria Hamill, Andrew Bathgate

JHEP Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortality.
Scott A McDonald, Stephen T Barclay, Hamish A Innes, Andrew Fraser, Peter C Hayes, Andrew Bathgate

J Viral Hepat· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
Scott A McDonald, Kevin G Pollock, Stephen T Barclay, David J Goldberg, Andrew Bathgate

J Viral Hepat· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.
Abdullah K Malik, Steven Masson, Elisa Allen, Murat Akyol, Andrew Bathgate

Transplantation· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study.
Scott A McDonald, Stephen T Barclay, Sharon J Hutchinson, Adrian J Stanley, Andrew Fraser, Andrew Bathgate

Aliment Pharmacol Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.
Elizabeth C Goode, Allan B Clark, George F Mells, Brijesh Srivastava, Kelly Spiess, Andrew Bathgate

Hepatology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy.
Arash Vaziri, Alexander Gimson, Kosh Agarwal, Mark Aldersley, Andrew Bathgate

J Viral Hepat· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for HBV.
Leanne Stratton, Andrew Bathgate

Aliment Pharmacol Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
Marco Carbone, Alessandra Nardi, Steve Flack, Guido Carpino, Nikoletta Varvaropoulou, Andrew Bathgate

Lancet Gastroenterol Hepatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRI.
Tim G St Pierre, Michael J House, Sander J Bangma, Wenjie Pang, Andrew Bathgate

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
Suman Verma, Fiona Hand, Matthew J Armstrong, Marie de Vos, Douglas Thorburn, Andrew Bathgate

Liver Transpl· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance-the T Mapping and ECV Standardization in cardiovascular magnetic resonance (T1MES) program.
Gabriella Captur, Peter Gatehouse, Kathryn E Keenan, Friso G Heslinga, Ruediger Bruehl, Andrew Bathgate

J Cardiovasc Magn Reson· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.
Marco Carbone, Stephen J Sharp, Steve Flack, Dimitrios Paximadas, Kelly Spiess, Andrew Bathgate

Hepatology· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autochthonous hepatitis E in Scotland.
Sandeep Ramalingam, Donald Smith, Louise Wellington, Jeff Vanek, Peter Simmonds, Andrew Bathgate

J Clin Virol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional representation software as image enhancement tool in small-bowel capsule endoscopy: a feasibility study.
Anastasios Koulaouzidis, Alexandros Karargyris, Emanuele Rondonotti, Colin L Noble, Sarah Douglas, Andrew J Bathgate

Dig Liver Dis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort.
Greta Pells, George F Mells, Marco Carbone, Julia L Newton, Andrew J Bathgate

J Hepatol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study.
George F Mells, Greta Pells, Julia L Newton, Andrew J Bathgate, Andrew K Burroughs

Hepatology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.
Richard S Tedder, Alison J Rodger, Lori Fries, Samreen Ijaz, Mark Thursz, Andrew Bathgate

Clin Infect Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis.
Jimmy Z Liu, Mohamed A Almarri, Daniel J Gaffney, George F Mells, Luke Jostins, Andrew J Bathgate

Nat Genet· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum phosphate is not a reliable early predictor of outcome in paracetamol induced hepatotoxicity.
Khee Lim Ng, J S Davidson, Andrew J Bathgate

Liver Transpl· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal disease in liver allograft recipients -- a clinicopathological study with follow-up.
Newton A C S Wong, Andrew J Bathgate, Christopher O C Bellamy

Eur J Gastroenterol Hepatol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis